Current UV Index
Adelaide
UV index: 0.2

UV index for Adelaide: 0.2 - LOW
Last updated Wednesday, 21 August 2019 at 8:29 am

Minimum recommended protection:

  • Wear sunglasses
Alice Springs
UV index: 0.8

UV index for Alice Springs: 0.8 - LOW
Last updated Wednesday, 21 August 2019 at 8:29 am

Minimum recommended protection:

  • Wear sunglasses
Brisbane
UV index: 2.0

UV index for Brisbane: 2.0 - LOW
Last updated Wednesday, 21 August 2019 at 8:59 am

Minimum recommended protection:

  • Wear sunglasses
Canberra
UV index: 1.1

UV index for Canberra: 1.1 - LOW
Last updated Wednesday, 21 August 2019 at 8:59 am

Minimum recommended protection:

  • Wear sunglasses
Darwin
UV index: 0.8

UV index for Darwin: 0.8 - LOW
Last updated Wednesday, 21 August 2019 at 8:29 am

Minimum recommended protection:

  • Wear sunglasses
Gold Coast
UV index: 2.1

UV index for Gold Coast: 2.1 - LOW
Last updated Wednesday, 21 August 2019 at 8:59 am

Minimum recommended protection:

  • Wear sunglasses
Kingston
UV index: 0.2

UV index for Kingston: 0.2 - LOW
Last updated Wednesday, 21 August 2019 at 8:59 am

Minimum recommended protection:

  • Wear sunglasses
Melbourne
UV index: 0.7

UV index for Melbourne: 0.7 - LOW
Last updated Wednesday, 21 August 2019 at 8:59 am

Minimum recommended protection:

  • Wear sunglasses
Newcastle
UV index: 1.8

UV index for Newcastle: 1.8 - LOW
Last updated Wednesday, 21 August 2019 at 8:58 am

Minimum recommended protection:

  • Wear sunglasses
Perth
UV index: 0.0
Sydney
UV index: 1.3

UV index for Sydney: 1.3 - LOW
Last updated Wednesday, 21 August 2019 at 8:59 am

Minimum recommended protection:

  • Wear sunglasses
Townsville
UV index: 2.2

UV index for Townsville: 2.2 - LOW
Last updated Wednesday, 21 August 2019 at 8:59 am

Minimum recommended protection:

  • Wear sunglasses

Click the indexes to view the minimum recommended protection

When the UV index is low, sun protection is generally not needed unless outside for extended periods

UV observations courtesy of ARPANSA
Disclaimer

Fast facts

  • Around 36 Australians are diagnosed with Melanoma every day.
  • Australia has one of the highest rates of Melanoma in the world.
  • Approx one person dies every 5 hours from Melanoma in Australia.
  • An estimated 545 Australian women will die from melanoma THIS YEAR.
  • Tanning beds emit dangerous UV rays, increasing the risk of Melanoma.
  • Severe sunburn during childhood can DOUBLE your risk of Melanoma.
  • Melanoma is one of the most preventable forms of cancer.
  • An estimated 1230 Australian men will die from melanoma THIS YEAR.
  • Melanoma is the cancer most likely to affect 15-39 year olds.
  • Melanoma can arise in normal looking skin, a mole or freckle.
  • Melanoma, if detected/treated early, has a survival rate of nearly 100%.
  • There is no cure for melanoma that has spread throughout the body.

Research

Our Focus

The AMRF is committed to funding research aimed at furthering knowledge and offering better outcomes in the prevention, diagnosis and treatment of melanoma.

Our aim is to support research that leads to a reduction in the incidence of melanoma and its impact on those living with the cancer.

The AMRF will focus on supporting early career researchers in Australia.

The Foundation has established an evaluation framework to assist in the identification of the key research areas to optimise our funding support.

Over the past few years the AMRF has provided funding to support research that has had a positive impact for some with melanoma.

Current Research Projects being funded:

- Improving Melanoma Therapy Using Timed Coordinated Vaccine & Chemotherapy Delivery: Timed vs Untimed VMCL Melanoma Vaccine Therapy Phase III Study for Patients with Advanced Stage IV Melanoma: Chief Investigator Prof Brendon Coventry, University of Adelaide.

- Targeting EPHB4 with bovine antibodies to cure melanoma – Dr Pablo Garcia Valtanen, Postdoctoral Research Associate at the School of Pharmacy and Medical Sciences, University of South Australia Cancer Research Institute.

Funding from the AMRF is supporting a PhD student to conduct laboratory tests towards a new treatment method to complement existing chemotherapy drugs.

Previously funded research projects include:

- Analysis of the completed EMOTIV (“Enhancing Melanoma Outcomes using a Timed Immunotherapy Vaccine”) Melanoma Vaccine Study

- Analysis of the cyclical behaviours of the human immune system as it effects vaccine therapies

- Analysis of the long-term survival outcomes in the VMCL (“Vaccinia Melanoma Cell Lysate”) Trial

- The effect of timing on the IL-2 (“Interleukin-2 Melanoma Therapy”)